Market Overview:
The global mestranol market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of gynecological disorders, increasing awareness about available treatment options, and growing demand for oral contraceptives. Based on type, the global mestranol market is segmented into kit and tablet. The kit segment is expected to grow at a higher CAGR than the tablet segment during the forecast period from 2018 to 2030. This can be attributed to increasing use of kits for diagnosis and treatment of gynecological disorders. Based on application, the global mestranol market is divided into abnormal uterine bleeding, endometriosis, hypermenorrhea, menstrual cramps, and polycystic ovarian syndrome (PCOS). The abnormal uterine bleeding segment accounts for a major share of the global mestranol market in terms of revenue. This can be attributed to high prevalence rate of this disorder across all regions studied in this research study.
Product Definition:
A synthetic form of the hormone progesterone, mestranol is used to prevent pregnancy and treat menstrual disorders. It is also sometimes prescribed to relieve menopausal symptoms.
Kit:
Kit is a kind of medical device used for the treatment of breast cancer. It works by removing the cancerous cells from the body. The kit consists of Mestranol and Lactobacillus that helps in reducing pain, improving appetite, and increasing quality of life for women during or after chemotherapy.
Tablet:
Tablet is a form of oral drug delivery system which comprises small pellets or spheroidal particles made up of gelatin, starch, and/or other carriers. It is designed to deliver the drug in powdered or pellet form which dissolves quickly on contact with stomach fluids and hence are known as disintegrating tablets.
Application Insights:
Menstrual cramps was the most prominent application segment in 2017. Mestranol is used as a primary treatment for various menstrual cramps including period pain, ovary pain, and abdominal pain. The drug also helps in reducing anxiety during menses and relieves fatigue due to heavy bleeding. In addition, it reduces blood loss during menstruation by increasing the number of white blood cells (WBCs) and Platelet Count (PLT).
The abnormal uterine bleeding segment held a significant share of market revenue in 2017 owing to rising awareness about menopausal symptoms coupled with increasing usage of oral contraceptives among women globally. This is anticipated to fuel demand over the forecast period as well since menopausal symptoms are often associated with anovulatory cycles or irregular periods which further leads to infertility if not addressed properly.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period. Increasing awareness regarding mental health and physical fitness among people of North America is one of the major factors responsible for maintaining dominance in this region. In addition, presence of key companies such as Actavis, Inc.; Mylan N.V.; Pfizer Inc.; and Merck & Co., Inc.
Asia Pacific is anticipated to be one of the fastest growing regions during the same period owing to increasing disposable income coupled with rising awareness about availability of effective treatment options for various disorders including menorrhagia.
In addition, expansion plans by leading manufacturers such as Actavis; Mylan N.V.; Pfizer Inc; and Merck & Co.
Growth Factors:
- Increasing awareness about the benefits of Mestranol among women
- Rising prevalence of hormonal imbalance in women
- Growing demand for contraceptives and birth control pills
- Technological advancements in the field of Mestranol synthesis and production
- Rising trend of self-medication among women
Scope Of The Report
Report Attributes
Report Details
Report Title
Mestranol Market Research Report
By Type
Kit, Tablet
By Application
Abnormal Uterine Bleeding, Endometriosis, Hypermenorrhea, Menstrual Cramps, Polycystic Ovarian Syndrome
By Companies
Thai Nakorn Patana, Teva, Aska Seiyaku Asuka, Pfizer, Johnson and Johnson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Mestranol Market Report Segments:
The global Mestranol market is segmented on the basis of:
Types
Kit, Tablet
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Abnormal Uterine Bleeding, Endometriosis, Hypermenorrhea, Menstrual Cramps, Polycystic Ovarian Syndrome
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thai Nakorn Patana
- Teva
- Aska Seiyaku Asuka
- Pfizer
- Johnson and Johnson
Highlights of The Mestranol Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Kit
- Tablet
- By Application:
- Abnormal Uterine Bleeding
- Endometriosis
- Hypermenorrhea
- Menstrual Cramps
- Polycystic Ovarian Syndrome
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mestranol Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mestranol is a medication used to treat moderate to severe pain. It works by reducing the amount of pain signals sent from the brain to the body. Mestranol is usually given as an injection into a muscle or under the skin.
Some of the major companies in the mestranol market are Thai Nakorn Patana, Teva, Aska Seiyaku Asuka, Pfizer, Johnson and Johnson.
The mestranol market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mestranol Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Mestranol Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Mestranol Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Mestranol Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Mestranol Market Size & Forecast, 2018-2028
4.5.1 Mestranol Market Size and Y-o-Y Growth
4.5.2 Mestranol Market Absolute $ Opportunity
Chapter 5 Global Mestranol Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Mestranol Market Size Forecast by Type
5.2.1 Kit
5.2.2 Tablet
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Mestranol Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Mestranol Market Size Forecast by Applications
6.2.1 Abnormal Uterine Bleeding
6.2.2 Endometriosis
6.2.3 Hypermenorrhea
6.2.4 Menstrual Cramps
6.2.5 Polycystic Ovarian Syndrome
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Mestranol Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Mestranol Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Mestranol Analysis and Forecast
9.1 Introduction
9.2 North America Mestranol Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Mestranol Market Size Forecast by Type
9.6.1 Kit
9.6.2 Tablet
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Mestranol Market Size Forecast by Applications
9.10.1 Abnormal Uterine Bleeding
9.10.2 Endometriosis
9.10.3 Hypermenorrhea
9.10.4 Menstrual Cramps
9.10.5 Polycystic Ovarian Syndrome
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Mestranol Analysis and Forecast
10.1 Introduction
10.2 Europe Mestranol Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Mestranol Market Size Forecast by Type
10.6.1 Kit
10.6.2 Tablet
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Mestranol Market Size Forecast by Applications
10.10.1 Abnormal Uterine Bleeding
10.10.2 Endometriosis
10.10.3 Hypermenorrhea
10.10.4 Menstrual Cramps
10.10.5 Polycystic Ovarian Syndrome
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Mestranol Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Mestranol Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Mestranol Market Size Forecast by Type
11.6.1 Kit
11.6.2 Tablet
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Mestranol Market Size Forecast by Applications
11.10.1 Abnormal Uterine Bleeding
11.10.2 Endometriosis
11.10.3 Hypermenorrhea
11.10.4 Menstrual Cramps
11.10.5 Polycystic Ovarian Syndrome
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Mestranol Analysis and Forecast
12.1 Introduction
12.2 Latin America Mestranol Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Mestranol Market Size Forecast by Type
12.6.1 Kit
12.6.2 Tablet
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Mestranol Market Size Forecast by Applications
12.10.1 Abnormal Uterine Bleeding
12.10.2 Endometriosis
12.10.3 Hypermenorrhea
12.10.4 Menstrual Cramps
12.10.5 Polycystic Ovarian Syndrome
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Mestranol Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Mestranol Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Mestranol Market Size Forecast by Type
13.6.1 Kit
13.6.2 Tablet
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Mestranol Market Size Forecast by Applications
13.10.1 Abnormal Uterine Bleeding
13.10.2 Endometriosis
13.10.3 Hypermenorrhea
13.10.4 Menstrual Cramps
13.10.5 Polycystic Ovarian Syndrome
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Mestranol Market: Competitive Dashboard
14.2 Global Mestranol Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thai Nakorn Patana
14.3.2 Teva
14.3.3 Aska Seiyaku Asuka
14.3.4 Pfizer
14.3.5 Johnson and Johnson
